NAT10 and prostate adenocarcinoma: Survival analysis using The Cancer Genome Atlas-Prostate Adenocarcinoma (TCGA-PRAD) data indicated a significant inverse correlation between NAT10 expression and progression-free survival, with higher NAT10 levels linked to poorer outcomes (Fig. 1e).